BUY Marksans Pharma Limited — Kunal Saraogi
byKunal SaraogiHorizon: NA (inferred Intraday)24 Sept 2026, 8:53 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·24 Sept · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Marksans Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services29 Sept 2026 · ~2 weeks · target ₹380 · SL hit
- BUY — IDBI Capital29 Sept 2026 · ~3 months · target ₹380 · SL hit
- BUY — Rajesh Satpute29 Sept 2026 · ~2 weeks · target ₹360 · SL hit
- BUY — Vinay Rajani, HDFC Securities24 Sept 2026 · ~2 weeks · target ₹370 · SL hit
- BUY — Kunal Hasmukhlal Shah23 Sept 2026 · Same day · target ₹349 · Expired
More from Kunal Saraogi
- BUY PB Fintech13 Nov 2026 · Same day · target ₹1,121 · Expired
- BUY Computer Age Management Services13 Nov 2026 · Same day · target ₹765 · SL hit
- BUY Central Depository Services (India)13 Nov 2026 · Same day · target ₹1,485 · Expired
- BUY Gabriel India12 Nov 2026 · ~2 weeks · target ₹1,600 · Target hit
- BUY Pine Labs12 Nov 2026 · ~2 weeks · target ₹176 · Target hit

